Sensus Healthcare, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Sensus Healthcare, Inc. on May 29, 2026. The filing details the outcomes of three specific matters submitted to a vote by security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following matters were voted upon at the Annual Meeting:
- Election of Directors: Eric Sachetta and Michael J. Sardano were elected as Class II directors for a three-year term expiring in 2029. Both were incumbent directors.
- Advisory Vote on Executive Compensation: Stockholders approved the compensation of named executive officers for 2025 on a non-binding advisory basis.
- Auditor Appointment Ratification: Stockholders ratified the appointment of Carr, Riggs & Ingram, LLC as the independent registered public accountant for the fiscal year ending December 31, 2026.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the tabulation of votes cast.
Key Facts for Investor Verification
- Director Election Support: Eric Sachetta received 5,532,247 votes "For" versus 516,567 "Against". Michael J. Sardano received 4,702,852 votes "For" versus 1,346,063 "Against".
- Compensation Vote: The advisory vote on 2025 executive compensation received 4,740,572 votes "For" and 856,128 votes "Against".
- Auditor Ratification: The appointment of Carr, Riggs & Ingram, LLC received overwhelming support with 10,738,792 votes "For" and 148,466 votes "Against".
- Broker Non-Votes: There were 5,000,719 broker non-votes recorded for the director elections and the executive compensation vote.